Goat and rat antisera directed against Friend leukemia virus (anti-FLV) were found to be B-lymphocyte mitogens stimulating DNA 
experiments with viable cells, the antigen involved in mitogenicity was found to be expressed on Friend erythroleukemia cell lines (4/4) and on myelomas (2/2) but not on normal thymus T lymphomas (0/2) or on rabbit or mink cells infected with BALB/c xenotropic virus. Preincubation of spleen cells with anti-gp7O antiserum inhibited the mitogenic effect of anti-FLV but not of lipopolysaccharide. Normal cells from various vertebrate species contain gene sequences coding for retroviruses. These endogenous viral genes have been hypothesized to play a role in physiological processes such as cell division and differentiation (1) . Conversely, alterations in the regulation of these genes or in their structural components may be involved in oncogenesis. The known laboratory strains of oncogenic type C viruses are related to and possibly derived from endogenous viruses.
For the last few years we have been interested in the expression of endogenous retroviruses in normal lymphoid cells of mice. We have found that B and T cells differ fundamentally with respect to virus expression. B cells can be induced to release virus after mitogenic stimulation; T cells cannot (2) (3) (4) . The virus-inducing B-cell mitogens also trigger physiological differentiation of B cells into immunoglobulin-secreting end cells (4, 5) . Hence, we have asked whether viral gene expression may be physiologically required for a humoral immune response. We have tested this possibility by injecting mice with antiserum directed against BALB/c endogenous xenotropic virus that was originally induced from B cells by lipopolysaccharide from Escherichia coli. We found that anti-xenotropic antiserum specifically blocked some early events of the humoral immune response (6, 7) . Evidence for endogenous viral gene expression on cells participating in an immune response has also been obtained by other workers (8) (9) .
Virus. FLV was purified by sucrose density-gradient centrifugation from the "Eveline" cell line, an infected STU fibroblastoid line (10 (11, 12) .
Rat anti-FLV antisera were raised against similarly prepared virus and tested after six weekly immunizations. Preimmunization sera were used for controls.
Monospecific rabbit antisera directed against gp70 of FLV as well as against the p30, p15, p12, plO, and pi5E components of FLV were kindly provided by W. Schafer. For a recent characterization of these antisera, see ref. 13 .
RESULTS
GaFLV proved to be a strong stimulator of DNA synthesis in BALB/c spleen cultures (Fig. 1 ). GaFLV produced a dosedependent mitogenic effect as measured by [3H]thymidine incorporation with maximal stimulation 3 days after treatment. Normal goat sera were consistently negative. The mitogenic activity of the antiserum was found to be in the immunoglobulin fraction (data not shown). To see whether anti-FLVs raised in species other than goat are also mitogenic, rats were immunized either with FLV or with AKR-xenotropic virus. All rat anti-FLV (five of five) were mitogenic, and maximal activity was observed at 1:100; at 1:20, a lower degree of stimulation was observed (Table 1 ). This inhibitory effect at the lower dilution is presumably due to antibody excess and represents the prozone effect frequently observed in serological reactions. With GaFLV we never observed a prozone effect; the nature of the difference between rat and goat antisera is not clear. Antisera from rats (Table 1) or rabbits (data not shown) immunized with AKR xenotropic virus had no mitogenic antibody at any dilution tested. In conclusion, mitogenic antisera can be readily prepared in goat and rats after immunization with FLV.
To test the specificity of the mitogenic effect, absorption experiments with various purified viruses were performed ( Mitogenicity was assayed on day 3 in BALB/c cultures as described in Fig. 1 To substantiate further the viral specificity of the mitogenic effect we tested monospecific antisera directed against purified components of FLV-i.e., against gp7O, p3O, p15, pi5E, p12, and plO. None of these were mitogenic for spleen cells. We considered the possibility that the critical antigen involved in the mitogenic effect was partially denatured during purification of FLV proteins used in the preparation of monospecific sera. Thus, the monospecific antisera would not bind to the same antigenic detevminant that is recognized by the mitogenic GaFLV. Alternatively, monospecific serum could contain the "right" antibody but in insufficient quantity or avidity to trigger the mitogenic signal. In these cases it seemed possible that monospecific antisera might prevent mitogenic GaFLV from acting.
Support for the latter possibility is demonstrated in the experiments presented in Table 3 . Preincubation of spleen cells for 90 min with anti-gp7O antiserum dramatically reduced the effect of GaFLV but did not affect the mitogenic effect of lipopolysaccharide. Anti-p3O antiserum had no effect. The anti-gp7O effect was seen in BALB/c, NFS/N, and 129 cultures. These results suggest a physical association or similarity of a membrane component crossreacting with gp7O and the mitogen receptor which becomes activated by GaFLV.
To determine whether it was B or T cells that were responding to GaFLV, we compared their effects on different lymphoid subpopulations (Fig. 4) a possible GaFLV-negative strain for later use in determining a genetic control of the mitogenic effect. Spleen cells from all strains tested reacted with GaFLV, with approximately 5% of their cells being positive for GaFLV fluorescence (Table 4) . Double-fluorescence revealed that the majority of cells found positive for viral antigen expressed iu chains, a finding consistent with the mitogenicity experiments (Fig. 4) showing that GaFLV reacts with B cells. Therefore, only a subpopulation of the total B cells expresses viral antigen. The cells expressing virus but not ,u chains have not been studied further. It is conceivable that they are B cells expressing immunoglobulin determinants of another class. (-) or goat GaFLV at 1:160 (0). DNA synthesis was measured as indicated in Fig. 1 . 
DISCUSSION
Mitogens of bacterial and plant origin have been useful for the study of lymphocyte activation. However, their disadvantage is that in addition to binding to the presumed mitogen receptor they bind to many other glycoproteins of the same and other cells. Hence, they are not ideal tools to identify biochemically the mitogen receptors involved in cell activation. In contrast, due to their inherent specificity, mitogenic antibodies can be expected to become important tools in defining receptor molecules for lymphocyte activation. Mitogenic antisera with specificity for B cells include antisera against the B-cell immunoglobulin receptor (16, 17) and against the B-cell lipopolysaccharide receptor (18) . Recently, an antiserum mitogenic for human B cells which reacts with a distinct glycoprotein has been described (19 endogenously occurring FMR-related gp7O has been described by Elder et al. (20) . The blocking of the GaFLV mitogenicity by preincubation with anti-gp7O serum (Table 4) seems to support this model.
A second possibility would be that the antibody reacts with a host-encoded structure, antigenically unrelated to virus, which becomes part of FMR viruses upon virus release. This mechanism is suggested by the demonstration that FLV grown in H-2b cells specifically incorporates H-2Db antigens (21) .
However, evidence that viral antigen is more directly involved in the mitogenic action of GaFLV comes from the effect of preincubation with monospecific anti-gp7O antiserum (Table  3) . It prevented GaFLV from being mitogenic but did not affect the action of bacterial lipopolysaccharide. Anti-p3O had no effect. We emphasize that these experiments have been carried out with low-virus-expressing mice such as 129, NFS/N, and young BALB/c because Lee and Ihle (22) have shown that anti-gp7O abolished the mitogenicity of phytohemagglutinin and lipopolysaccharide but only with cells from virus-expressing mice such as AKR and old BALB/c. These authors have suggested that in virus-producing cells the viral gp70 becomes inserted into the membrane near a mitogen receptor and that, upon binding, anti-gp70 antiserum affects this receptor function (22) .
The fluorescence data of Table 4 indicated that a minority population of B cells reacts with anti-FLV. Two lines of evidence, to be presented elsewhere, suggest that we deal with a distinct subpopulation of B cells. First, in double-fluorescence experiments, spleen cells reacted either with antiserum against the lipopolysaccharide receptor, a known marker for a B-cell subpopulation (19) , or with GaFLV but never with both. Furthermore, when spleen cells were pretreated with GaFLV and complement, the GaFLV-reacting population could be eliminated whereas the subpopulation reacting with lipopolysaccharide remained unaltered. It will be interesting to determine the functional significance of the GaFLV-reactive subpopulation.
It is important to distinguish between the mitogenic antiserum discussed here and the previously reported immunosuppressive antiserum directed against BALB/c xenotropic virus (anti-MuLV-X serum) (6, 7) . Neither serum has the activity of the other-i.e., GaFLV is not immunosuppressive and antiMuLV-X antiserum is not mitogenic. They act on different target cell populations. GaFLV, as shown here, acts on a subset of B cells, and anti-MuLV-X serum reacts predominantly with T-helper cells and B cells (unpublished data). Nevertheless, the cellular component recognized by both antisera might be the same. We have suggested (7) that the immunosuppressive anti-MuLV-X antiserum might block a receptor structure functioning in a T-B cell interaction or receiving proliferation/differentiation signals. In this hypothetical model, antibody prevents a "signal" from reaching the B cell. Antibodies have also been reported to activate receptors directly. For example, antibody to insulin receptor has insulin-like effects (23) . Thus, it could well be that GaFLV activates a similar receptor that is being blocked by anti-MuLV-X antiserum on antigenreactive B cells.
In an immune response, antigen binding to antigen-reactive cells is required but is not sufficient to trigger those cells to proliferate into effector cells. Additional "signals," specific and nonspecific ones derived from T cells and macrophages, are required. These signals are still not clearly defined, and even less is known about the receptor structures on B cells to which they bind. Our results suggest that components crossreacting with retroviruses may be closely related to receptor structures required for lymphocyte activation. Thus, infection of lymphocytes with a helper virus might have functional consequences resulting in immunosuppression or preneoplastic proliferation, as discussed elsewhere (5) .
